Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals
  • Print
  • Share
  • E-mail
-

Start of page content Return to search Page to restart searchReturn to Orphan Designation Search PageReturn to Search Page
Generic Name:gabapentin
Trade Name:Gralise
Date Designated: 11-08-2010
Orphan Designation:Management of postherpetic neuralgia
Orphan Designation Status: Designated/Approved
FDA Orphan Approval Status:Approved for Orphan Indication
Approved Labeled Indication:For the management of postherpetic neuralgia. 
Marketing Approval Date: 01-28-2011
Exclusivity End Date: N\A
Depomed, Inc.
1360 O'Brien Drive
Menlo Park, CA 94025-1436

The sponsor address listed is the last reported by the sponsor to OOPD.

-
-